
Validea's guru fundamental report rates UNITEDHEALTH GROUP INC (UNH) at 77% using its Martin Zweig Growth Investor model, a strategy known for its historical outperformance. While UNH, a large-cap health insurer, passes key criteria like P/E ratio and current quarter earnings, its overall score falls just shy of the 80% threshold for strategic interest, primarily due to inconsistencies in revenue growth relative to EPS and earnings growth over the past several quarters.
UnitedHealth Group (UNH) receives a 77% rating from Validea's Martin Zweig-based Growth Investor model, indicating a fundamentally sound company that falls just short of the 80% threshold for a clear buy signal under this specific quantitative strategy. The analysis reveals a bifurcated performance profile. On the positive side, UNH passes crucial tests for its P/E ratio, sales growth rate, long-term EPS growth, earnings persistence, and favorable insider transactions. The current quarter's earnings performance is particularly strong, showing positive growth and exceeding the growth rates of the prior three quarters. However, the model flags significant inconsistencies in growth acceleration, which are central to the Zweig methodology. UNH fails the criteria for revenue growth relative to EPS growth, earnings growth rate over the past several quarters, and its current EPS growth fails to exceed its historical rate. This suggests that while current performance is robust, the longer-term trend lacks the persistent acceleration that the model seeks for a high-conviction investment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment